IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. (IDXX) — Form 144: Proposed sale of shares
AI-generated summary
Jonathan J Mazelsky, Officer and Director of IDEXX Laboratories, Inc., proposed to sell 25,140 shares of common stock with an aggregate market value of $17,678,196.60 through Morgan Stanley Smith Barney LLC Executive Financial Services. The approximate sale date is November 4, 2026. The shares to be sold were acquired through a stock option exercise on November 4, 2026.
Key facts
- Seller
- JONATHAN J MAZELSKY
- Relationship
- Officer, Director
- Shares to sell
- 25,140
- Market value
- $17,678,196.60
- Approximate sale date
- Nov 4, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Nov 4, 2026 · Stock Option Exercise
More IDXX filings
- 144
Filed Nov 4, 2026
- 144
Filed Nov 4, 2026
- 144
Filed Nov 4, 2026
- 4
Filed Nov 3, 2026
- 10-Q
Filed Nov 2, 2026
- 8-K
Filed Nov 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.